-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $270

Benzinga·02/17/2026 16:27:47
Listen to the news
Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $240 to $270.